Bibliografía del artículo
1. Kibar Z, Capra V, Gros P. Toward understanding the genetic basis of neural tube defects. Clin Genet 71:295-310, 2007.
2. Bassuk A, Kibar Z. Genetic basis of neural tube defects. Semin Pediatr Neurol 16:101-10, 2009.
3. Fenichel GM. Clinical Pediatric Neurology: A signs and symptoms approach. Sexta edición, Elsevier Health Sciences España; 2009.
4. Nussbaum RL, Mcinnes RR, Willard HF. Genética en medicina. 7 ed. Elseiver Masson, España; 2008.
5. Suárez F, Ordóñez A, Zarante I. Defectos del tubo neural y ácido fólico: patogenia, metabolismo y desarrollo embriológico. Revisión de la literatura. Rev Colomb Obstet Ginecol 60:49-60, 2010.
6. Pachajoa H, Caicedo CA, Saldarriaga W, Méndez F. Prevalencia de defectos congénitos en un hospital de tercer nivel en Cali, Colombia 2004-2008, asociación con edad materna. Rev Colomb Obstet Ginecol 62:155-160, 2011.
7. Weitkamp LR, Tackels DC, Hunter AG, Holmes LB, Hchwartz CE. Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives. Lancet 351:1554-5, 1998.
8. Nitsche FV, Alliende MA, Santos JL, Pérez F, María Santa L, Hertrampf E, Cortés F. Frecuencia del polimorfismo C677T de la 5,10-metilentetrahidrofolato reductasa MTHFR en mujeres chilenas madres de afectados con espina bífida y en controles normales. Rev Méd Chile 131:1399-1404, 2003.
9. Jiménez Salas Z, Cantú Martínez PC, Berrún Castañón LN, González Martínez BE. Polimorfismos de la metilentetrahidrofolato reductasa y su asociación con los defectos del tubo neural. Rev Salud Publica Nutr 2:1-6, 2001.
10. Gutiérrez J, Pérez F, Calvo M, Tamparillas M, Romero J. Implicación de los polimorfismos C677T y A1298C del gen MTHFR en el desarrollo de los defectos del tubo neural en la población española. Med Clin 120:441-45, 2003.
11. González Galofre Z, Villegas V, Martínez Agüero M. Determinación del polimorfismo C677T de metilentetrahidrofolato reductasa MTHFR en una población piloto de estudiantes de la Universidad del Rosario, Rev Cienc Salud 8:7-21, 2010.
12. Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects IV, Taiwan J Obstet Gynecol 47:141-50, 2008.
13. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151, 1995.
14. Van der Put NM, Van der Molen EF, Kluijtmans LA, Heil SG, Trijbels JM, Eskes TK, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocisteinaemia in neural-tube defects and vascular disease. Q J Med 90:511, 1997.
15. Johanning GL, Wenstrom KD, Tamura T. Changesin frequencies of heterozygous thermolabile 5,10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects. J Med Genet 39:366-7, 2002.
16. Sopó O. Evaluación de la asociación de los polimorfismos C677T, A1298C de la MTHFR, 844INS68, C699T de la CBS y A66G de la MTHFR con los defectos del tubo neural [tesis de maestría], Bogotá, Colombia: Pontifica Universidad Javeriana; 2011.
17. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleflip. Am J Med Genet 80:196, 1998.
18. Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328:1535-6, 2004.
19. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch S, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256, 2004.
20. Pietrzyk JJ, Bik-Multanowski M, Sanak M, Twardowska M. Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 44:111, 2003.
21. Zhang T, Lou J, Zhong R, Wu J, Zou L, Sun Y, et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One 4:8e59570, 2013.
22. Yan L, Zhao L, Long Y, Zou P, Ji G, Gu A, et al. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. Plos One 710:e41689, 2012.
23. StataCorp, Stata 11. Base Reference Manual, College Station, TX: Stata Press, 2009.
24. Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, Finnell R. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab 70:45-52, 2000.
25. Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda S, Quintero-Rivera F, et al. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Am J Epidemiol 81:933-7, 2006.
26. Cardona H, Cardona-Maya W, Gómez JG, Castañeda SJ, Gómez M, Bedoya G, et al. Relación entre los polimorfismos de la metilentetrahidrofolato-reductasa y los niveles de homocisteína en mujeres con pérdida gestacional recurrente: perspectiva desde la nutrigenética. Nutrición Hospitalaria 23:277-82, 2008.
27. Camacho Vanegas O, Giusti B, Restrepo Fernández CM, Abbate R, Pepe G. Frequency of factor V FV Leiden and C677T methylenetetrahidrofolate reductase MTHFR mutations in Colombians. Thromb Haemost 79:883-4, 1998.
28. Bermúdez M, Briceño I, Gil F, Bernal J. Homocisteína y polimorfismos de cistationina sintasa y metilentetrahidrofolato reductasa en población sana de Colombia. Colombia Médica 37:46-52, 2006.
29. Li DH, Ahmed M, Li YN, Jiao L, Chou TH, Wolff RA, et al. 5,10-methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1470-6, 2005.
30. Alluri RV, Mohan V, Komandur S, Chawda K, Chaudhuri JR, Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12:40-4, 2005.
31. Pepe G, Vanegas OC, Giusti B, Brunelli T, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Amer J Hum Genet 63:917, 1998.
32. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Amer J Hum Genet 62:1258, 1998.
33. Li DH, Ahmed M, Li YN, Jiao L, Chou TH, Wolff RA, et al. 5,10-methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1470-6, 2005.
34. Ilhan N, Kucuksu M, Kaman D, Ilhan N, Ozbay Y. The 677C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39:125-30, 2008.
35. Van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, Van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-71, 1995.
36. Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, Finnell R. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab 70:45, 2000.
37. Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, et al. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res 33:102-7, 2009.
38. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12:1222-6, 2003,
39. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348-58, 1997.
40. Decreto por el cual se reglamenta la fortificación de la harina de trigo y se establecen las condiciones de comercialización, rotulado, vigilancia y control. Decreto 1944 de 1996, Diario Oficial No, 42,909, de 30 de octubre de 1996.